Correlation Between Purple Biotech and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Inhibikase Therapeutics, you can compare the effects of market volatilities on Purple Biotech and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Inhibikase Therapeutics.
Diversification Opportunities for Purple Biotech and Inhibikase Therapeutics
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Purple and Inhibikase is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Purple Biotech i.e., Purple Biotech and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Purple Biotech and Inhibikase Therapeutics
Given the investment horizon of 90 days Purple Biotech is expected to under-perform the Inhibikase Therapeutics. In addition to that, Purple Biotech is 1.41 times more volatile than Inhibikase Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Inhibikase Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 366.00 in Inhibikase Therapeutics on September 12, 2024 and sell it today you would lose (46.00) from holding Inhibikase Therapeutics or give up 12.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Purple Biotech vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Purple Biotech |
| Inhibikase Therapeutics |
Purple Biotech and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Purple Biotech and Inhibikase Therapeutics
The main advantage of trading using opposite Purple Biotech and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
| Inhibikase Therapeutics vs. Equillium | Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Valneva SE ADR | Inhibikase Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |